Even if the pain is mild or hard on the brain

Published Date: 08 Mar 2023

A new study shows structural and functional changes in the brain associated with anxiety and depression after mild COVID-19 infection.

Read Full News

Latest News

Hormone Therapy and Thrombosis: What Clinicians May Miss?

Route of administration, patient history, and formulation choice may shape thrombotic risk more than clinicians previously recognized.

When Does a Tick Bite Need Antibiotics?

The guidance varies depending on the tick and whether it is in endemic area for illnesses like Lyme disease.

Liver & Colorectal Conditions: How New Data Will Impact Care

In this DDW 2026 update, Dr David Johnson reviews key advances in cirrhosis care, GLP-1 benefits, earlier HCC detection, colorectal cancer risks, and IL-23-targeted IBD therapies.

Stool Metabolites May Predict Crohn’s Complications

Fecal metabolomic profiling in Crohn’s disease reveals distinct metabolite patterns linked to disease activity, location, and complication risk.

Specific Risk Factors Make Difficult-to-Treat RA More Likely

Researchers conducted a meta-analysis of 21 studies to find lifestyle factors and comorbidities that raise odds for having difficult-to-treat rheumatoid arthritis.

Stress and Neighborhood Support Affect Sleep Among Teens

Feeling more stressed is linked to irregular sleep patterns and problems in teens, whereas living in a supportive neighborhood is linked to steadier sleep patterns.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

Route of administration, patient history, and formulation choice may shape thrombotic risk more than clinicians previously recognized.

The guidance varies depending on the tick and whether it is in endemic area for illnesses like Lyme disease.

In this DDW 2026 update, Dr David Johnson reviews key advances in cirrhosis care, GLP-1 benefits, earlier HCC detection, colorectal cancer risks, and IL-23-targeted IBD therapies.

Fecal metabolomic profiling in Crohn’s disease reveals distinct metabolite patterns linked to disease activity, location, and complication risk.

Researchers conducted a meta-analysis of 21 studies to find lifestyle factors and comorbidities that raise odds for having difficult-to-treat rheumatoid arthritis.

Feeling more stressed is linked to irregular sleep patterns and problems in teens, whereas living in a supportive neighborhood is linked to steadier sleep patterns.

News All Time

Free Birth Movement Presents Ethical Quandary: Ethicist

Art Caplan discusses the medical ethics involved in a free birth that went terribly wrong.

Obesity Management After Unsuccessful Dieting

A 45-year-old woman with a BMI of 38 kg/m2 presents with obesity despite lifestyle modifications. This case discussion on obesity highlights management strategies with novel incretin-based therapies.

The Ivermectin Paradox in Oncology

Dr Arturo Loaiza-Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ‘miracle cure’ myths while maintaining patient trust.

TikTok and the Squatty Potty: Seeking Help for Constipation

Two studies take different approaches to improving constipation, one examining the influence of TikTok and the other examining the effect of physical positioning.

Peptides Lack Reliable Safety Information, Watchdog Warns

As peptides for wellness surge in popularity, two safety groups warn many users may be injecting unapproved substances with little evidence they are safe or effective.

Adjunctive Antipsychotics for Major Depression Ranked

A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

Exoskeletons Set the Pace in Amyotrophic Lateral Sclerosis

The new exoskeleton technology combines biomechanics, sensors, and patient feedback to support gait training and rehabilitation in amyotrophic lateral sclerosis.

FDA Expands Vyvgart Approval to All Adults With gMG

The label expansion will include adults with AChR-Ab-negative gMG, making efgartigimod the first and only approved treatment for all serotypes of the rare neuromuscular disease.

Caring for the Carers: The NHS's Blind Spot

Millions of unpaid carers are damaging their own health — and slipping through the cracks of a system that should catch them.

Cholangitis: 1 Day of Antibiotics Noninferior to 4-7 Days

Compared with the recommended 4- to 7-day antibiotic course, a 1-day regimen achieved similar clinical cure rates, with no differences in mortality or other outcomes.

IgA Nephropathy: Advances Drive a Wave of New Therapies

New understanding about the pathophysiology of the condition, along with new clinical trial endpoints for approval, have resulted in a flood of new treatments.

Recurrent UTIs Within 6 Months May Signal Cancer Risk

Individuals presenting with repeated UTIs experience longer diagnostic delays and poorer outcomes than those presenting with hematuria.

Acute Liver Failure: 5 Things to Know

Acute liver failure requires rapid recognition and intervention, with delays associated with significantly increased mortality risk.

What’s Really Going on in Aging Tendons and Ligaments

Staying active your whole life means avoiding injury. Connective tissue may not get the same love muscles do but these strategies can mitigate risk.

New Data: US Psilocybin Use Reaches 8 Million

About 8 million people in the US use psilocybin, which is linked to depression, alcohol use disorder, cannabis use, and prescription drug misuse, a new study shows.

Genotype-Guided SSRI Prescribing Offers Mixed Results

Use of genotype-guided SSRI shows no symptom improvement at 3 months in people with depression but is linked to higher remission rates at 6 months.

Recommended News For You

How 7,000 steps a day could help reduce your risk of cancer

Future of Lab-Developed Tests Still Taking Shape

Daily physical activity, even at light intensities, linked to lower cancer risk

Study offers clearer picture of childhood brain tumor survival

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

FDA Authorizes Three Different Uses for Injectable Antibiotic.

One possible target in acute myeloid leukemia is the reductive carboxylation of glutamine.

Recommended Articles For You

Understanding Villous Adenoma: Causes, Symptoms, and Treatments 

Seeing Beyond the Pink Ribbon: AI's New Battle Against Breast Cancer 

Understanding Apoplexy: Symptoms, Causes, and Treatment Options  

Understanding Pomalidomide: A promising drug for multiple myeloma treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

2.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

3.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

4.

Prostate cancer therapies: AI-based image analysis detects early organ damage

5.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

1.

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing

2.

A New Hope: Exploring the Benefits of Exenteration for Cancer Patients

3.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

4.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

5.

Bridging the Global Divide: Enhancing Psychosocial Care for Cancer Survivors Across Income Settings

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

2.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

4.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot